PTSD can make the past feel startlingly present. A sound, smell, image, or ordinary moment can pull you into alarm before you have time to think. If you have tried treatment and still feel trapped by symptoms, it is understandable to wonder whether ketamine could offer another path.
At HavenNexus Advanced Psychiatry & TMS, we believe that question deserves more than a quick yes or no. Our psychiatric services begin with the person in front of us. We consider your history, symptoms, prior care, physical health, and goals. IV ketamine may be part of a PTSD conversation for some people. It is not a standalone answer, and it is not right for everyone.
PTSD is more than feeling stressed
PTSD is a mental health condition that can develop after experiencing or witnessing trauma. It can involve intrusive memories, nightmares, avoidance, changes in mood or thinking, sleep disruption, hypervigilance, irritability, or detachment from others. Symptoms vary from person to person. They can also overlap with depression, anxiety, substance use concerns, and other conditions.
The VA's description of PTSD reflects how broadly the condition can affect thoughts, emotions, relationships, and responses to perceived danger (U.S. Department of Veterans Affairs, n.d.). That is why careful assessment matters. The goal is not simply to lower a score on a questionnaire. It is to understand what you are carrying and what may help you regain steadiness in daily life.
If PTSD symptoms come with thoughts of suicide, a plan to harm yourself, or an inability to stay safe, call or text 988. The 988 Suicide & Crisis Lifeline provides 24/7 crisis support in the United States (988 Suicide and Crisis Lifeline, n.d.). You can also call 911 or go to the nearest emergency department.
What IV ketamine is, and what it is not
Ketamine is a medication long used in anesthesia. In psychiatric care, IV ketamine is sometimes considered because its effects differ from those of traditional daily psychiatric medications. A review of ketamine and related interventions describes the growing clinical and scientific interest in these treatments, while also emphasizing the need for thoughtful study and care models (Kelly et al., 2023).
For psychiatric uses, including PTSD, IV ketamine is off-label. This means the FDA has not approved IV ketamine as a treatment for PTSD. Off-label does not mean casual care. It means the decision should be individualized and medically informed. You deserve a frank discussion of possible benefits, limitations, risks, alternatives, and monitoring.
We approach ketamine therapy with thoughtful screening, not a one-size-fits-all protocol. Ketamine is also not the same as SPRAVATO®. SPRAVATO® is an esketamine nasal spray with FDA-approved indications related to depression. It should not be presented as a PTSD treatment. When discussing options, we make those distinctions clearly. The details matter.
What PTSD ketamine research has found so far
The evidence is encouraging enough to warrant serious attention. It is not settled enough to support broad promises. Ketamine-specific PTSD research includes relatively small clinical studies and reviews. Some have found short-term reductions in PTSD symptoms after treatment. However, the studies differ in dose, setting, number of sessions, participant characteristics, and outcome measures.
A recent review of novel PTSD interventions identifies ketamine as an area of active investigation, while noting the need for more precise and rigorous research (Dodds et al., 2025). In practical terms, we still have important unanswered questions. We do not know which people are most likely to benefit. We do not have one standard PTSD-specific IV ketamine protocol. We also need stronger evidence about how long any symptom changes may last.
This uncertainty matters because PTSD is rarely isolated from the rest of your life. Sleep, depression, anxiety, substance use, medical conditions, current medications, and safety concerns can all shape treatment planning.
A few limits are especially important to keep in view:
- A change in symptoms during a study does not tell us exactly who will benefit in everyday clinical care.
- Short-term improvement does not automatically establish lasting benefit.
- Ketamine can involve dissociation, altered perception, nausea, anxiety, or blood pressure changes.
- Those experiences may be particularly important to consider when trauma has affected your sense of safety or control.
There is also reason to avoid oversimplifying psychotherapy alongside ketamine. In a 2025 help-seeking sample, research comparing ketamine alone with ketamine plus psychotherapy found no additional benefit from the combined approach for depression or PTSD outcomes in that sample (Moore et al., 2025). This does not mean therapy is unimportant. It means we should not promise that one add-on format will improve outcomes for every person.
Trauma-informed care changes the conversation
For someone with PTSD, the treatment setting matters. Feeling pressured, rushed, misunderstood, or out of control can be deeply counterproductive. A trauma-informed approach recognizes the value of safety, choice, trust, collaboration, and clear communication.
A review of trauma-informed practices in psychedelic therapy research highlights the importance of preparation, consent, boundaries, and support around altered-state treatments (Modlin et al., 2024). Research settings are not identical to routine clinical care. Still, the lesson is practical. You deserve to know what is being proposed, why it is being considered, what you may experience, and how concerns will be addressed.
We take time to ask clinically relevant and personally important questions. What treatments have you tried? What helped, even a little? What made things worse? Are there current safety concerns? What support do you have after an appointment? A good plan makes room for those answers.
Deciding whether IV ketamine belongs in your care plan
An evaluation for PTSD is not a test you pass or fail. It is a conversation about fit. At HavenNexus Advanced Psychiatry & TMS in Palm Coast, FL, we consider IV ketamine for PTSD within a broader psychiatric picture. That includes your diagnosis, health history, medication list, treatment history, substance use history, and current stability.
We may also discuss psychiatric evaluation or medication management, therapy with an appropriately trained mental health professional, sleep support, routine changes, and other steps that fit your needs. The right next step may be ketamine. It may also be further assessment, a different form of care, or a plan that begins with safety and stabilization.
Please share if you have experienced psychosis, mania, uncontrolled blood pressure, significant substance-related concerns, or a difficult response to dissociation. These factors do not replace an individualized assessment. They can materially affect whether ketamine is appropriate and how we think about risk.
Questions worth bringing to your appointment
You do not need to arrive with all the answers. You can begin with a few direct questions:
- Is IV ketamine appropriate to consider for my PTSD and health history?
- What are realistic goals of treatment in my situation?
- What side effects or difficult experiences should I prepare for?
- How will we monitor safety before, during, and after treatment?
- What other approaches should be part of my PTSD care?
- How will we decide whether to continue, adjust, or stop?
Bring records of prior treatment when available. This may include medications, therapy history, and past psychiatric diagnoses. That context helps us make a more informed recommendation. Your story is not a blank slate.
If you are looking for a careful conversation about PTSD and off-label IV ketamine, you can schedule an appointment with our team. You can also review insurance and fee information or contact our clinic at (386) 247-0840. We will meet your questions with honesty, clinical attention, and respect for the complexity of what you have lived through.
Works Cited
1. U.S. Department of Veterans Affairs, National Center for PTSD. PTSD. https://www.ptsd.va.gov/
2. 988 Suicide and Crisis Lifeline. https://988lifeline.org/
3. Kelly DF, et al. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. https://pubmed.ncbi.nlm.nih.gov/36512813/
4. Dodds C, et al. Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine. https://pubmed.ncbi.nlm.nih.gov/41362593/
5. Moore TM, et al. Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample. https://pubmed.ncbi.nlm.nih.gov/40203964/
6. Modlin NL, et al. Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions. https://pubmed.ncbi.nlm.nih.gov/38268571/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.